- $1.46bn
- $1.38bn
- $534.53m
AtriCure Inc expected to post a loss of 18 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Evoqua Water Technologies, Taysha Gene Therapies, Veradigm
Brief: AtriCure Announces First Patient Treated In The LeAAPS Clinical Trial
Brief: Atricure Reports Preliminary Results For Fourth Quarter And Full Year 2022, Provides Financial Outlook For 2023
U.S. RESEARCH ROUNDUP-Avista, IPG Photonics, Seaspine Holdings
AtriCure Inc reports results for the quarter ended in September - Earnings Summary
Brief: Atricure Reports Third Quarter 2022 Financial Results
AtriCure Inc expected to post a loss of 25 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Esperion Therapeutics, Sierra Wireless, WW Grainger
Brief: AtriCure Reports Second Quarter 2022 Financial Results
AtriCure Inc expected to post a loss of 29 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Anthem, Scotts Miracle-Gro, Vornado Realty Trust
AtriCure Inc reports results for the quarter ended in March - Earnings Summary
Brief: AtriCure Reports First Quarter 2022 Financial Results
AtriCure Inc expected to post a loss of 32 cents a share - Earnings Preview
Medical device makers likely to give conservative outlook in Q1 - SVB Leerink
U.S. RESEARCH ROUNDUP-Advance Auto Parts, Airbnb, Marriott
AtriCure Inc reports results for the quarter ended in December - Earnings Summary
Brief: AtriCure Reports Fourth Quarter 2021 And Full Year 2021 Financial Results